Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Diffuse Large B-Cell Lymphoma
3:02
Phase I study of rapcabtagene autoleucel in patients with R/R DLBCL
Nirav Shah
• 15 Feb 2023
5:36
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy
Veit Buecklein
• 9 Dec 2022
1:23
CARBON trial: investigating CTX110 allogeneic CRISPR-Cas9–engineered CAR-Ts in R/R LBCL
Constantine Tam
• 12 Dec 2022
5:09
Mechanisms of resistance to CAR T-cell therapies
John Rossi
• 26 Aug 2021
2:13
CAR-T in DLBCL: 4-year follow-up data from ZUMA-1
Anna Sureda
• 9 Feb 2021
2:15
The future of CAR T-cell therapy in lymphoma
Anna Sureda
• 9 Feb 2021
1:44
Liso-cel for R/R large B-cell lymphoma
Ulrich Jäger
• 9 Feb 2021
3:05
Real-world efficacy & safety data: CAR-T in DLBCL
Matthew Frigault
• 1 Sep 2020
1:45
Challenges associated with CAR T-cell production
Valentín Ortiz-Maldonado
• 1 Sep 2020
4:28
Selecting DLBCL patients for CAR T-cell therapies
Anna Sureda
• 1 Sep 2020
2:18
Tocilizumab: CAR T-cell therapy in DLBCL
Matthew Frigault
• 1 Sep 2020